{"altmetric_id": 83946256, "counts": {"readers": {"citeulike": "0", "mendeley": "63", "connotea": "0"}, "total": {"posts_count": 16}, "twitter": {"unique_users_count": 11, "posts_count": 13}, "patent": {"unique_users_count": 3, "unique_users": ["patent:US-10787501-B1", "patent:US-10954289-B1", "patent:US-10975139-B1"], "posts_count": 3}}, "citation": {"altmetric_jid": "532721422a83ee84788b4567", "authors": ["Hurlburt, Nicholas K.", "Wan, Yu-Hsin", "Stuart, Andrew B.", "Feng, Junli", "McGuire, Andrew T.", "Stamatatos, Leonidas", "Pancera, Marie"], "doi": "10.1101/2020.06.12.148692", "first_seen_on": "2020-06-13T05:09:42+00:00", "issns": [], "journal": "bioRxiv", "last_mentioned_on": 1618272000, "links": ["https://www.biorxiv.org/content/10.1101/2020.06.12.148692v1", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301900/", "https://doi.org/10.1101/2020.06.12.148692"], "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/06/12/2020.06.12.148692.full.pdf", "pmid": "32577631", "publisher": "Cold Spring Harbor Laboratory", "title": "Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/5fc7da09-719e-3af0-9a49-54f0ae9cef3a/"}, "altmetric_score": {"score": 8.5, "score_history": {"1y": 8.5, "6m": 3, "3m": 3, "1m": 0, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 8.5}, "context_for_score": {"all": {"total_number_of_other_articles": 17709629, "mean": 9.4408698303018, "rank": 2782021, "this_scored_higher_than_pct": 84, "this_scored_higher_than": 14921737, "rank_type": "exact", "sample_size": 17709629, "percentile": 84}, "similar_age_3m": {"total_number_of_other_articles": 295322, "mean": 19.602302388579, "rank": 68084, "this_scored_higher_than_pct": 76, "this_scored_higher_than": 227075, "rank_type": "exact", "sample_size": 295322, "percentile": 76}, "this_journal": {"total_number_of_other_articles": 120900, "mean": 13.89449139785, "rank": 44072, "this_scored_higher_than_pct": 63, "this_scored_higher_than": 76746, "rank_type": "exact", "sample_size": 120900, "percentile": 63}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 8634, "mean": 17.668017373176, "rank": 3147, "this_scored_higher_than_pct": 63, "this_scored_higher_than": 5483, "rank_type": "exact", "sample_size": 8634, "percentile": 63}}}, "demographics": {"poster_types": {"member_of_the_public": 8, "researcher": 2, "practitioner": 1}, "users": {"twitter": {"cohorts": {"Members of the public": 8, "Practitioners (doctors, other healthcare professionals)": 1, "Scientists": 2}}, "mendeley": {"by_status": {"Professor > Associate Professor": 1, "Researcher": 12, "Student  > Master": 5, "Student  > Ph. D. Student": 8, "Professor": 1, "Student  > Bachelor": 11, "Student  > Doctoral Student": 1, "Lecturer": 1, "Other": 6, "Librarian": 3, "Lecturer > Senior Lecturer": 1, "Student  > Postgraduate": 1, "Unspecified": 2}, "by_discipline": {"Medicine and Dentistry": 18, "Social Sciences": 1, "Psychology": 1, "Pharmacology, Toxicology and Pharmaceutical Science": 1, "Environmental Science": 2, "Unspecified": 2, "Chemical Engineering": 1, "Engineering": 3, "Chemistry": 3, "Economics, Econometrics and Finance": 1, "Immunology and Microbiology": 4, "Agricultural and Biological Sciences": 3, "Nursing and Health Professions": 3, "Business, Management and Accounting": 1, "Biochemistry, Genetics and Molecular Biology": 9, "Veterinary Science and Veterinary Medicine": 1}}}, "geo": {"twitter": {"US": 4, "NL": 1}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "1949132852"}, "tweet_id": "1271662792169476098"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "1054460958226157568"}, "tweet_id": "1271662793117380609"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "525984544"}, "tweet_id": "1271664723365441541"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "985699594850918400"}, "tweet_id": "1271671605807075329"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "1080590070313295874"}, "tweet_id": "1271833542129926145"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "1244711417657376768"}, "tweet_id": "1271988302313390080"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1272287371568930816"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "1271336113756614656"}, "tweet_id": "1272427171513073664"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "4416084738"}, "tweet_id": "1272484059554492419"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1279830614426955778"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1279830887841050627"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1280304802082234368"}, {"license": "gnip", "citation_ids": [83946256], "author": {"tweeter_id": "117262129"}, "tweet_id": "1321731607800111104"}], "patent": [{"title": "Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10787501-B1", "license": "public", "citation_ids": [81686823, 79886706, 83946256, 81839528, 81950522, 78627096, 82099898, 84234572, 82123095, 81432678, 81687333, 84590251, 82776439, 82125287, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 82372636, 83326754, 83146578, 82236864, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 83816209, 76759624, 82241906, 82006689, 82127390, 83471779, 81898802, 82752495, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 79411573, 82846613, 84064050, 82136174, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 89309738, 92789824, 93046290, 42295981, 2000877, 4443560, 1927968, 4498119, 80912392], "posted_on": "2020-09-29T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10787501-B1", "jurisdiction": "US", "filing_status": "Grant"}, {"title": "Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10954289-B1", "license": "public", "citation_ids": [81687333, 84590251, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 81686823, 79886706, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 82372636, 83326754, 83146578, 82236864, 83946256, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 82776439, 82125287, 83816209, 76759624, 4225088, 82241906, 82006689, 82127390, 84234572, 82123095, 81839528, 83471779, 81898802, 82752495, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 79411573, 81331345, 82846613, 84064050, 82136174, 81432678, 81950522, 78627096, 82099898, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 76348331, 78651983, 89309738, 86397980, 92789824, 83360939, 93046290, 42295981, 83349805, 84959013, 2000877, 79801422, 76810504, 4443560, 82104617, 1927968, 4498119, 80912392], "posted_on": "2021-03-23T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10954289-B1", "jurisdiction": "US", "filing_status": "Grant"}, {"title": "Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10975139-B1", "license": "public", "citation_ids": [81687333, 84590251, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 81686823, 79886706, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 83326754, 83146578, 82236864, 83946256, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 82776439, 82125287, 83816209, 76759624, 82241906, 82006689, 82127390, 84234572, 82123095, 81839528, 83471779, 81898802, 82752495, 4225088, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 81331345, 82846613, 84064050, 82136174, 81432678, 81950522, 78627096, 82099898, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 76348331, 78651983, 89309738, 86397980, 92789824, 83360939, 93046290, 42295981, 83349805, 84959013, 2000877, 79801422, 76810504, 4443560, 82104617, 1927968, 4498119, 80912392], "posted_on": "2021-04-13T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10975139-B1", "jurisdiction": "US", "filing_status": "Grant"}]}, "score": 8.5, "images": {"small": "https://badges.altmetric.com/?size=64&score=9&types=aatttttt", "medium": "https://badges.altmetric.com/?size=100&score=9&types=aatttttt", "large": "https://badges.altmetric.com/?size=180&score=9&types=aatttttt"}}